Therefore, FABP4 could endow colon cancer cells with mesenchymal properties, characterized by reducing cell-to-cell adhesion regulated by E-cadherin, and increasing the expressions of mesenchymal biomarkers. Here, CDH1 is linked to colonic neoplasm.